Review Article

Overview of Helicobacter pylori Infection, Prevalence, Risk Factors, and Its Prevention

Table 3

Prospects in the management of H. pylori infection.

(i) Susceptibility-guided therapy/antibiotic sensitivity testing
(ii) PPI-high dose
(iii) Novel antibiotics
(iv) Clarithromycin avoidance, if used previously
(v) Antibiotic course for 14 days
(vi) Probiotics with antibiotics
(vii) Vonoprazan (P-CAB) instead of PPI
(viii) PCR/DNA extraction (from stool sample) for making a diagnosis
(ix) Nanotechnology use